Royal College of Obstetricians & Gynaecologists (RCOG) World Congress 2023

Levonorgestrel-piroxicam combo prevents pregnancy after unprotected sex

Elaine Soliven, 20230725000000

The use of levonorgestrel (LNG) plus piroxicam, as oral emergency contraception (EC) after unprotected sexual intercourse (UPSI), resulted in a significantly greater number of pregnancies prevented compared with LNG plus placebo, according to a study presented at RCOG 2023.

Adverse neurodevelopmental outcomes higher in complicated twins

Audrey Abella, 20230720100000

Survivors of complicated monochorionic diamniotic (MCDA) twin pregnancies (ie, complicated twins) have a higher rate of adverse neurodevelopmental outcomes compared with uncomplicated twins, suggests a study presented at RCOG 2023.

Tranexamic acid use before CS reduces blood loss

Elaine Soliven, 20230714000000

The use of prophylactic tranexamic acid (TXA) prior to elective Caesarean section (CS) led to significantly lower blood loss in women, particularly those at high risk for postpartum haemorrhage (PPH), according to a study presented at RCOG 2023.

Singaporean cohort study: Menopausal women now more symptomatic

Jairia Dela Cruz, 20230705140000

Menopause occurs at about 50 years of age for Singaporean women, and almost two out of three of them experience moderate-to-severe symptoms, as shown in a study presented at RCOG 2023.

Is it safe to use biologic drugs in pregnancy?

Stephen Padilla, 20230705120000

Among the biologic drugs used during pregnancy, the most common is tumour necrosis factor-α antagonist (etanercept-infliximab-adalimumab), results of a clinical review have shown.

Migraine tied to adverse pregnancy outcomes

Stephen Padilla, 20230704120000

Pregnant women with migraine appear to have an increased likelihood of experiencing pre-eclampsia, low birth weight, peripartum mental illness, preterm birth, and placental abruption, according to a study presented at the recent RCOG 2023.

Heparin unable to prevent miscarriages in women with inherited thrombophilia

Jairia Dela Cruz, 20230701100000

Daily shots of low-molecular weight heparin (LMWH) fall short of improving live birth rates for women with a history of at least two pregnancy losses and inherited thrombophilia, according to the results of the open-label trial ALIFE2.